Elisa Sala

BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells

Elisa Sala, Luca Mologni, Silvia Truffa et al. · Molecular Cancer Research · 2008 · 185 citations

Mutant Braf, Cell Regulation, Braf Silencing +14

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

Molecular Screening for Hereditary Nonpolyposis Colorectal Cancer: A Prospective, Population-Based Study

Antonio Percesepe, Francesca Borghi, Mirco Menigatti et al. · Journal of Clinical Oncology · 2001 · 104 citations

Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting

Iván Plaza-Menacho, Luca Mologni, Elisa Sala et al. · Journal of Biological Chemistry · 2007 · 97 citations · Full text

Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.

Monica Pedroni, Elisa Sala, A Scarselli et al. · PubMed · 2001 · 74 citations

Tumor Biology, Genome Instability, Cancer Pathology +15